Find Phenidone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 92-43-3, 1-phenylpyrazolidin-3-one, 1-phenyl-3-pyrazolidinone, 1-phenyl-3-pyrazolidone, Fenidon, 3-pyrazolidinone, 1-phenyl-
Molecular Formula
C9H10N2O
Molecular Weight
162.19  g/mol
InChI Key
CMCWWLVWPDLCRM-UHFFFAOYSA-N
FDA UNII
H0U5612P6K

Phenidone
1 2D Structure

Phenidone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-phenylpyrazolidin-3-one
2.1.2 InChI
InChI=1S/C9H10N2O/c12-9-6-7-11(10-9)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,10,12)
2.1.3 InChI Key
CMCWWLVWPDLCRM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(NC1=O)C2=CC=CC=C2
2.2 Other Identifiers
2.2.1 UNII
H0U5612P6K
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Phenidone Monohydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 92-43-3

2. 1-phenylpyrazolidin-3-one

3. 1-phenyl-3-pyrazolidinone

4. 1-phenyl-3-pyrazolidone

5. Fenidon

6. 3-pyrazolidinone, 1-phenyl-

7. Pyrazolidinone, 1-phenyl-

8. 1-phenyl-3-oxopyrazolidine

9. 2-pyrazolin-3-ol, 1-phenyl-

10. 1-p-3-p

11. 1-phenyl-pyrazolidin-3-one

12. 1-phenylpyrazolid-3-one

13. Chembl7660

14. 1-phenyl-4,5-dihydro-1h-pyrazol-3-ol

15. Mls002639322

16. H0u5612p6k

17. Nsc-30306

18. Ccris 3624

19. Einecs 202-155-1

20. 3-pyrazolidinone,1-phenyl-

21. Unii-h0u5612p6k

22. Phenidone A

23. Mfcd00003094

24. Wln: T5nmvtj Ar

25. N-phenylpyrazolidin-3-one

26. Chemdiv3_006595

27. Timtec1_001225

28. Dsstox_cid_29393

29. Dsstox_rid_83508

30. 1-phenyl Pyrazolidine-3-one

31. Dsstox_gsid_49433

32. Oprea1_428400

33. Schembl235192

34. Schembl9670254

35. Dtxsid1049433

36. Schembl10371905

37. 1-phenyl-3-pyrazolidinone, 97%

38. Hms1491l17

39. Hms1537h15

40. Hms3091p11

41. Hms3886e10

42. Albb-010492

43. Nsc30306

44. Zinc2769764

45. Tox21_202877

46. 1-phenyltetrahydro-3h-pyrazol-3-one

47. Bdbm50009004

48. S5520

49. Stk084358

50. Stk741678

51. Akos000119161

52. Akos003264132

53. (phenidone)1-phenyl-pyrazolidin-3-one

54. 1-phenyl-pyrazolidin-3-one(phenidone)

55. Ccg-207926

56. Cs-w010860

57. Fs-4504

58. Hy-w010144

59. Sdccgmls-0064787.p001

60. Cas-92-43-3

61. Idi1_024505

62. 1-phenyl-3-pyrazolidinone [mi]

63. 1-phenyl-pyrazolidin-3-one (phenidone)

64. Ncgc00174656-01

65. Ncgc00260423-01

66. Smr001548767

67. Db-057302

68. Ft-0608244

69. P0153

70. D78316

71. Sr-01000516084

72. Q-200133

73. Q3297749

74. Sr-01000516084-1

75. F0905-7615

76. 14776-33-1

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 162.19 g/mol
Molecular Formula C9H10N2O
XLogP30.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass162.079312947 g/mol
Monoisotopic Mass162.079312947 g/mol
Topological Polar Surface Area32.3 Ų
Heavy Atom Count12
Formal Charge0
Complexity175
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Cyclooxygenase Inhibitors

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)


Lipoxygenase Inhibitors

Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)


Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty